Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR)
β Scribed by Takada, Yukiko ;Tachizawa, Hidetaka ;Kurihara, Hiroko ;Takayanagi, Motoe ;Sasamoto, Takahiro ;Akashi, Masahiro ;Aiso, Mitsuhiko ;Takamori, Yoriyuki ;Sano, Naoyo ;Takikawa, Hajime
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 136 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have previously demonstrated that the HMG-CoA reductase inhibitor pravastatin is efficiently taken up by the liver via the 'multispecific anion transporter' in an active manner.3 To further examine the fate of pravastatin within the liver, its biliary excretion was studied in a single-pass liver
Recent evidence indicates that the renin-angiotensin system (RAS) plays a major role in liver fibrosis. Here, we investigate whether the circulatory RAS, which is frequently activated in patients with chronic liver disease, contributes to fibrosis progression. To test this hypothesis, we increased c